MGX
Metagenomi, Inc.
1.20$
+1.8%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +0.3% | -10.0% | +79.3% | -42.5% | -16.5% | -57.1% | +106.3% | +1.7% | -54.8% | -68.1% | -120.6% | – | |
| – | -7.8% | +27.0% | -95.8% | – | – | +1,620.9% | -10.5% | -94.1% | -1.8% | -33.6% | – | – | |
| – | – | – | – | -42.5% | -16.5% | -318.6% | – | – | -64.4% | -85.3% | -166.8% | – | |
| – | -7.8% | +27.0% | -9.9% | -7.3% | -11.8% | +8.5% | -10.5% | +6.5% | -10.3% | -10.2% | +16.6% | – | |
| – | -1.0% | +11.6% | -2.3% | -10.6% | -7.4% | -3.8% | +2.8% | -11.1% | +9.0% | -3.6% | -8.1% | – | |
| – | -1.0% | +11.6% | +321.3% | -8.1% | -10.8% | -77.5% | +2.8% | +331.5% | -10.6% | -7.4% | +14.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +126.0% | -244.3% | – | – | – | – | -55.1% | -631.8% | – | -129.4% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.